Sinopharm Group Co (HKSE:01099) Accounts Payable : HK$169,259 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Sinopharm Group Co Accounts Payable?

Sinopharm Group Co's Accounts Payable for the quarter that ended in Dec. 2023 was HK$169,259 Mil.

Sinopharm Group Co's quarterly Accounts Payable declined from Jun. 2023 (HK$171,329 Mil) to Sep. 2023 (HK$0 Mil) but then increased from Sep. 2023 (HK$0 Mil) to Dec. 2023 (HK$169,259 Mil).

Sinopharm Group Co's annual Accounts Payable declined from Dec. 2021 (HK$162,691 Mil) to Dec. 2022 (HK$161,496 Mil) but then increased from Dec. 2022 (HK$161,496 Mil) to Dec. 2023 (HK$169,259 Mil).

Sinopharm Group Co Accounts Payable Historical Data

The historical data trend for Sinopharm Group Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Group Co Accounts Payable Chart

Sinopharm Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

121,201.34

138,377.41

162,691.15

161,495.59

169,259.47

Sinopharm Group Co Quarterly Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															161,495.59	171,328.94	-	169,259.47	-

Sinopharm Group Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Sinopharm Group Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Sinopharm Group Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Group Co (HKSE:01099) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinopharm Group Co Ltd (HKSE:01099) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

SHTDY:USA SHTDF:USA X2S:Germany X2S:Germany

Address

No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023

Website

http://www.sinopharmgroup.com.cn

Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.

Sinopharm Group Co (HKSE:01099) Headlines

No Headlines